Table II Patient demographics
Median age58.4 (30.3–76)
Tumor types
Median 28 day cycles on therapy4.75 (0.5–36.5)
Best response
    Partial response5
    Stable disease19
    Progressive disease3
    Not evaluable1
  • a Other includes the following: adrenocortical, papillary renal cell, cervical, colon, peritoneal mesothelioma, uterine papillary serous, unknown primary, papillary thyroid, rectal squamous, adenoid cystic breast, and granulosa cell cancers (one each).